About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Abiomed Impella RT-DAQ - Observational Study | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT06308055

Abiomed Impella RT-DAQ - Observational Study

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Lead sponsor: Abiomed Inc.•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Abiomed Inc.

The objective of this study is to develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module, which can replace invasive hemodynamic monitoring in the future.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Ongoing or planned intensive care management with Impella support
•2. Presence or planned placement of a cardiac output measurement
•1. Preferentially pulmonary catheter (including cardiac output (CO) preferred as continuous measurement)
•2. Other means of discontinuous CO measurement incl. echocardiography, other thermodilution methods

Exclusion Criteria

•1. Age \< 18 years
•2. Pregnancy
•3. Anticipated support duration \<24 h

Related studies

Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock

NCT06638268 · Aortic Stenosis, Cardiogenic Shock

Altshock-2 REGISTRY

NCT04295252 · Cardiogenic Shock

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

NCT07515508 · Cardiogenic Shock, Acute Heart Failure (AHF)

RECRUITINGPhase 4

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

NCT05168462 · Cardiogenic Shock, Myocardial Infarction

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

NCT04419480 · Cardiogenic Shock, Heart Failure, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment125

Start dateOct 2024

Last updatedOct 1, 2025

Condition

Cardiogenic Shock

Locations shown

Uniklinik RWTH Aachen

Aachen, North Rhine-Westphalia

UKSH Campus Kiel

Kiel, Schleswig-Holstein

Asklepios Klinik Altona

Hamburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions